On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds

…, SSF Leung, AS Kalgutkar, JN Bauman… - Nature chemical …, 2011 - nature.com
Backbone N-methylation is common among peptide natural products and has a substantial
impact on both the physical properties and the conformational states of cyclic peptides. …

Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors

RL Walsky, JN Bauman, K Bourcier, G Giddens… - Drug Metabolism and …, 2012 - ASPET
The measurement of the effect of new chemical entities on human UDP-glucuronosyltransferase
(UGT) marker activities using in vitro experimentation represents an important …

Kinetics of Acetaminophen Glucuronidation by UDP-Glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential Implications in Acetaminophen− Induced …

AE Mutlib, TC Goosen, JN Bauman… - Chemical research in …, 2006 - ACS Publications
The importance of uridine 5‘-diphosphate-glucuronosyltranferases (UGT) 2B15 and other
UGT enzymes (1A1, 1A6, and 1A9) in glucuronidating acetaminophen (APAP) is demonstrated…

Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug

JN Bauman, KS Frederick, A Sawant, RL Walsky… - Drug metabolism and …, 2008 - ASPET
In vitro metabolism/bioactivation of structurally related central nervous system agents
nefazodone (hepatotoxin) and aripiprazole (nonhepatotoxin) were undertaken in human liver …

Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies

GS Walker, JN Bauman, TF Ryder, EB Smith… - Drug Metabolism and …, 2014 - ASPET
The contribution of drug metabolites to the pharmacologic and toxicologic activity of a drug
can be important; however, for a variety of reasons metabolites can frequently be difficult to …

The pharmacokinetics, metabolism, and clearance mechanisms of abrocitinib, a selective Janus kinase inhibitor, in humans

JN Bauman, AC Doran, A King-Ahmad… - Drug Metabolism and …, 2022 - ASPET
Abrocitinib is an oral once-daily Janus kinase 1 selective inhibitor being developed for the
treatment of moderate-to-severe atopic dermatitis. This study examined the disposition of …

Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid

TC Goosen, JN Bauman, JA Davis, C Yu, SI Hurst… - Drug metabolism and …, 2007 - ASPET
Gemfibrozil coadministration generally results in plasma statin area under the curve (AUC)
increases, ranging from moderate (2- to 3-fold) with simvastatin, lovastatin, and pravastatin to …

Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure–activity relationships and strategies for the elimination of reactive …

DP Walker, FC Bi, AS Kalgutkar, JN Bauman… - Bioorganic & medicinal …, 2008 - Elsevier
The synthesis and SAR for a series of diaminopyrimidines as PYK2 inhibitors are described.
Using a combination of library and traditional medicinal chemistry techniques, a FAK-…

Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes

VC Peterkin, JN Bauman, TC Goosen… - British journal of …, 2007 - Wiley Online Library
… The samples were then centrifuged at 14 000 rpm (15 000 g) for 10 min, supernatants
removed, mixtures dried under N 2 and reconstituted in mobile phase consisting of 84% 20 mm …

In vitro kinetic characterization of axitinib metabolism

…, TC Goosen, E Tseng, J Lin, JN Bauman… - Drug Metabolism and …, 2016 - ASPET
N-Methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide (axitinib) is an
oral inhibitor of vascular endothelial growth factor receptors 1–3, which is approved for the …